by Ludwig Maximilian University of Munich Data-driven cutoff for the CSF Aβ42/40 ratio regarding Aβ PET positivity and evaluation of a two-cutoff approach in the German (LMU) and Austrian (MUV) cohort. Credit: Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (2024). DOI: 10.1002/dad2.70031 The first drugs against Alzheimer’s disease that are intended to slow down the progression of...
Author: admin
Post
Why Do Your Farts Smell Foul? Common Causes of Stinky Farts
Written by Samantha C. Shapiro, MD | Reviewed by Christine Giordano, MD Updated on June 25, 2024print_outlinedemail_outlined Key takeaways: Prostock-Studio/iStock via Getty Images Passing gas, farting, or cutting the cheese. No matter what you call it, everyone does it. On some days, people fart more than others. And on other days, farts are smellier — and those days...
Post
Do Not Crush List: These Common Medications Should Always Stay Intact
Written by Rachel Feaster, PharmD, BCOP, BCPS | Reviewed by Ashlyn Clark, PharmD Candidate, Christina Aungst, PharmD Published on April 4, 202 Key takeaways: Table of contents Why it matters Do not crush list Knowing when it’s safe Tips for swallowing pills Bottom line References Fahroni/iStock via Getty Images Plus Do you get anxiety at the thought of having...
Post
New schizophrenia drug could treat Alzheimer’s disease
Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed. Medicines for schizophrenia are being investigated to treat other brain disorders.Credit: K H Fung/Science Photo Library Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in September, some researchers have...
Post
The Impact of Glucagon on Diabetes Management
By Dr. Liji Thomas, MDReviewed by Danielle Ellis, B.Sc. Understanding glucagon: The counterpart to insulinThe role of glucagon in diabetesGlucagon-Like Peptide-1 (GLP-1): A key player in diabetes managementThe future of glucagon therapyReferencesFurther reading Understanding glucagon: The counterpart to insulin Glucagon is a peptide hormone secreted primarily from the alpha cells of the pancreatic islets of Langerhans. Minor...
Post
EARLIER DIABETES DIAGNOSIS MEANS HIGHER DEMENTIA RISK
NOVEMBER 22ND, 2024POSTED BY RACHEL HARRISON-NYU (Credit: Getty Images) SHARE THIS ARTICLE You are free to share this article under the Attribution 4.0 International license. TAGS UNIVERSITY NEW YORK UNIVERSITY People diagnosed with type 2 diabetes at a younger age are at a higher risk for developing dementia than those diagnosed later in life, according to a new...
Post
SCIENCE & TECHNOLOGY NEWS
Folic acid may mitigate link between lead exposure during pregnancy and autistic behaviours in children Posted Yesterday New research gives another reason to take folic acid supplements while pregnant. Pregnancy – illustrative photo. Image credit: Pixabay (Free Pixabay license) A new study by Simon Fraser University researchers has found that folate may weaken the link between blood-lead levels in pregnant...
Post
Chemicals produced by fires show potential to raise cancer risk
Posted Yesterday Derek Urwin has a special stake in his work as a cancer control researcher. After undergraduate studies in applied mathematics at UCLA, he became a firefighter. His inspiration to launch a second career as a scientist was the loss of his brother, Isaac, who died of leukemia at only 33 despite no history of...
Post
Hidden pocket in human bitter taste receptor discovered
Peer-Reviewed Publication The Hebrew University of Jerusalem image: A view of the bitter anti-inflammatory Flufenamic acid (orange) at the TAS2R14 (green) binding pocket.view more Credit: [Figure reproduced from Peri, Matzov, Huxley, et al, 2024.] “Tasting Upside-Down – An Unusual Sensing Mechanism was Found in Human Bitter Sensing” A new study revealed that some bitter molecules target...
Post
Study reveals new way to unlock blood-brain barrier, potentially opening doors to treat brain and nerve diseases
Peer-Reviewed Publication The Mount Sinai Hospital / Mount Sinai School of Medicine image: Brain barrier-crossing conjugates enable the systemic delivery of large therapeutic molecules to the brain. Credit: Lab of Yizhou Dong, PhD, at Icahn Mount Sinai. New York, NY [November 25, 2024]—Researchers at the Icahn School of Medicine at Mount Sinai have developed an...